Genzyme rejects Sanofi-Aventis’ $18.5B offer
- August 31, 2010
- World Business
Biotechnology company Genzyme rejects Sanofi-Aventis SA’s $18.5 billion buyout offer, saying the bid undervalues the company.
Genzyme – Sanofi-Aventis – Business – United States – Biotechnology and Pharmaceuticals
